Join a Legacy of Innovation 110 Years and Counting!

Daiichi Sankyo Group is dedicated to the creation and supply of innovative pharmaceutical therapies to improve standards of care and address diversified, unmet medical needs of people globally by leveraging our world-class science and technology. With more than 100 years of scientific expertise and a presence in more than 20 countries, Daiichi Sankyo and its 16,000 employees around the world draw upon a rich legacy of innovation and a robust pipeline of promising new medicines to help people. Under the Group’s 2025 Vision to become a “Global Pharma Innovator with Competitive Advantage in Oncology,” Daiichi Sankyo is primarily focused on providing novel therapies in oncology, as well as other research areas centered around rare diseases and immune disorders.

Summary

The purpose of this role is to develop and drive the Global HEOR and RWE strategies for the assigned oncology franchise products, in alignment with key global and regional functions. The Global Director of HEOR & RWE Oncology will lead the HEOR and RWE implementation and evidence generation for a successful market access strategy across Daiichi-Sankyo. He/She will drive the asset specific HEOR strategy and coordinate all corresponding HEOR and RWE activities under the Global Oncology Market Access & Pricing department for the Oncology Business Unit, in collaboration with cross-functional teams. The role will be responsible for the HEOR and RWE strategy and tactical plans, including the implementation of global health economic models, global value dossiers, RWE studies, PRO analysis, and will drive development of innovative tools, methods, and strategies to ensure successful market access and support the company's vision of being a leader in oncology and deliver the innovative Daiichi Sankyo's treatments to patient. The position will be a key and visible expert leader, he/she will engage the clinical, Medical Affairs and commercial organization and drive the product evidence strategies to ensure an effective use of HEOR and RWE methods. The Director will provide HEOR and RWE strategic direction to Global Project Teams (GPTs) and Global Brand Teams (GBTs) and provide recommendations on such aspects as appropriate comparators, target patient populations, clinical and economic end-points and patient-reported outcomes (PROs), ensuring the payer perspective is incorporated in the assigned clinical development programs and the evidence needed to support optimal market access. Furthermore, the role will contribute with HEOR sections in target product profiles (TPPs), product development plans, clinical development plans, and commercialization plans and other critical documents.

Responsibilities

• Lead the preparation of global value dossiers which present the product value propositions and the supporting evidence, aligned with the product development strategies and approved/endorsed by the GPTs, GBTs, Regional HEOR and market access, to realize an optimal value demonstration of the products

• Plan and conduct HEOR and RWE studies such as early economic models, burden of illness studies, external control arms to support single arm trials, and drive the development, analysis, and validation of patient-reported outcome (PRO) instruments in clinical trials

• Conducts literature reviews to build payer evidence, economic models, and Global Value Dossiers

• Propose and implement analysis of clinical trial data for cost effectiveness models and market specific ad-hoc requests for reimbursement submissions

• Assess RWE data gaps and building cross-functional evidence generation strategy for payers and reimbursement submissions

• Build global cost effectiveness and budget impact models for HTA submissions to support reimbursement for indications of Daiichi Sankyo’s oncology productsDevelop HEOR and RWE communications (e.g. manuscripts, scientific forum presentations, slide decks, symposia), in collaboration with multi-functional teams, to build the peer reviewed published evidence supporting the value propositions for assigned productsEffectively manage the entire process for projects outsourced to external consultancies and contractors, ensuring delivery according to key milestones, budget and to agreed and expected quality

• Maintain and continue to enhance knowledge about HEOR methods and the evolving public health policy and reimbursement environment in major (USA, Europe and Japan) and other pertinent marketsLead team to ensure cross-functional collaboration between Global Market Access and Pricing and other internal stakeholders such as Medical Affairs, Clinical Development, Marketing, Biostats, etc.

Qualifications: Successful candidates will be able to meet the qualifications below with or without a reasonable accommodation.

Education Qualifications (from an accredited college or university)

• Master's Degree in a relevant discipline (e.g., health economics, medicine, pharmacy, public health, epidemiology) required

• PhD in a relevant discipline (e.g., health economics, medicine, pharmacy, public health, epidemiology) preferred

Experience Qualifications

• 10 or More Years in the healthcare or pharmaceutical industry, 8 of which must be working in the HEOR field

• Hands on experience with HEOR methodologies across all phases of the product life cycle preferred

• Track record of successful application of HEOR & RWE with key external stakeholders in major international markets

• Knowledge and experience of Oncology therapy areas is strongly preferred

• Demonstrates understanding and (advanced) knowledge of key drug development processes, plans, studies, and strategies including clinical, regulatory, scientific, operational, and commercial aspects of drug development. Uses knowledge to the organization’s advantage; generates new ideas and enables the organization to improve business performance.

• Demonstrates understanding and (advanced) knowledge of HEOR methods and RWD, and the issues and challenges of applying these alongside clinical studies in drug development. Applies this knowledge to design HEOR strategies and RWE studies

• Demonstrates deep understanding of the commercial and market access policy environment across major markets and harnesses this knowledge to design effective HEOR evidence development strategies to support optimal market access for DS medicines

• Strong influencing skills and ability to navigate in a martix organization, with proven ability to work cross-functionally, build coalitions and develop strong partnerships across functions

• Demonstrates strategic thinking, team leadership

• Experience within a pharmaceutical industry, consulting, or equivalent organization involved in research and development of healthcare technologies and/or delivery solutions

• Outstanding writing and presentation skills and ability to work under pressure, to take accountability for business challenges, think strategically and tackle complex problems

• Intellectual curiosity and ability to identify trends and emerging patters in areas such as RWE, HEOR, HTA assessments, Market Access, and Healthcare delivery and payer requirements

Travel

Ability to travel up to 30%

Daiichi Sankyo, Inc. is an equal opportunity/affirmative action employer. Qualified applicants will receive consideration for employment without regard to sex, gender identity, sexual orientation, race, color, religion, national origin, disability, protected veteran status, age, or any other characteristic protected by law.

At the heart of Daiichi Sankyo, Inc. is the fundamental belief that each employee helps shape our success. We have created an exceptional working environment that values and rewards individual contributions, but we also believe in the power of collaboration. We provide employees with the training, tools and technology that they need to excel. Our open communication, emphasis on results, and spirit of personal accountability are hallmarks of our corporate culture and ensures that each employee’s unique abilities are valued and utilized. We invite you to consider a career at Daiichi Sankyo, Inc.